Clinical trial
Epoetin Beta in Treating Anemia in Patients With Cervical Cancer
NCT00046969 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00046969 |
|---|---|
| Title | Epoetin Beta in Treating Anemia in Patients With Cervical Cancer |
| Official title | Management Of Anemia Under RadioChemotherapy (MARCH): An Open, Randomized Multicenter Study Of The Effect Of NeoRecormon On Treatment Outcome In Patients With Advanced Cervical Cancer Stage IIB -IVA Treated With Primary Simultaneous Radiochemotherapy (Radiotherapy Plus Cisplatin) |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia, Cervical Cancer |
| Intervention type | Biological, Drug, Radiation |
| Interventions | epoetin beta, cisplatin, brachytherapy, radiation therapy |
| Enrollment | 450 |
| Start date | Jul 1, 2002 |
| Completion | Jun 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | May 30, 2013 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: